- The Warm up Show

TV Reality Show

Reality television is a genre of television programming which presents purportedly unscripted dramatic or humorous situations, documents actual events, and features ordinary people instead of professional actors. Although the genre has existed in some form or another since the early years of television, the term reality television is most commonly used to describe programs produced since 2000. Documentaries and nonfictional programming such as the news and sports shows are usually not classified as reality shows.

More Articles from Video Streaming Information:

JPMorgan, Amazon and Berkshire Hathaway have named surgeon Atul Gawande as head of their new healthcare venture. Gawande’s focus on how the profit motive skews treatment for patients is spot on, but as Robert Cyran explains, he has his work cut out.

Rob Cyran tells Richard Beales why drug companies aren’t developing new antibiotics, how reliance on today’s treatments poses a $100 trillion risk to the world economy, and what government agencies are doing to try to incentivize the creation of new drugs.

Years after shutting its Chinese search engine, the U.S. tech giant has taken a $550 mln stake in, the country’s closest equivalent to Amazon. It’s probably less about access to China, and more about a global pitched battle between online giants, as Robert Cyran explains.

June 15 - The giant Chinese telecom equipment maker was given a reprieve from a U.S.-imposed death sentence, but is back on life support as Congress tries to undo the Trump administration’s rescue deal. Robyn Mak and Jeffrey Goldfarb discuss ZTE’s fate.

June 14 - The U.S. cable company is being uncharacteristically bold with its $65 billion bid for bits of Fox. Winners include shareholders in Sky, the UK firm that’s caught in the middle. Comcast is in a better place than AT&T, which just pushed the button on its mega-bid for Time Warner.

June 13 - What’s next after AT&T got the green light to buy Time Warner? More deals are likely, but the logic and benefit for viewers is uncertain at best, argues Jen Saba. Meanwhile, the shadow of Netflix continues to loom.

Investors are speculating on a possible $58 bln deal by artificial-joint maker Stryker to buy Boston Scientific. After a string of big device mergers, Rob Cyran says any bid would get close antitrust scrutiny — and invite others to do deals before it’s too late.

KKR’s $6 bln purchase of Envision follows several private-equity deals in the U.S. healthcare sector. Going private can spare companies from some of the outrage that surrounds high prices, but as Robert Cyran explains, hospitals will remain under pressure to nip and tuck.

Investment banks will soon able to take control of their securities joint ventures in China. Alec Macfarlane tells Quentin Webb why it’s important for the foreigners to pick their battles, and why the equities business could prove particularly tricky.

As Italy’s new government gets a green light from parliament, Milan columnist Lisa Jucca and Rob Cox check in from Rome’s Villa Borghese to discuss the implications. © 2018